GlaxoSmithKline (GSK)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

1,421.50p
   
  • Change Today:
    -2.00p
  • 52 Week High: 1,497.00p
  • 52 Week Low: 1,205.00p
  • Currency: UK Pounds
  • Shares Issued: 5,036m
  • Volume: 7,337,610
  • Market Cap: £71,582m
  • RiskGrade: 74
  • Beta: 0.52

Detailed GlaxoSmithKline Share Price Data

Share Price 1,421.50p Close 1,421.50p
Change Today -2.00p Volume 7,337,610
Percent Change -0.14 % Day High / Low 1,431.39p / 1,410.00p
Update Time 16:52:08 Year High / Low 1,497.00p / 1,205.00p
Bid 1,401.00p Last Trade Price 1,421.15p
Offer 1,445.00p Last Trade Amount 5,600
Open 1,416.00p Last Trade Time 16:51:58

Detailed GlaxoSmithKline Share Price Changes

Period Price Change Percent Change
1 week 1,410.00p +11.50p +0.82%
1 month 1,427.50p -6.00p -0.42%
3 months 1,422.50p -1.00p -0.07%
6 months 1,404.50p +17.00p +1.21%
1 year 1,348.00p +73.50p +5.45%

Additional Share Price Data

Ex-Marker Code Ex-Dividend NMS 1,750
Ex-Marker Start 09-May-12 VWAP 1,421.58p
Ex-Marker End 05-Jul-12 Beta 0.52

Related Market Prices

Index / Sector Value Change Percent Change
FTSE 100 5,405.25 -32.37 -0.60%
FTSE 350 2,870.16 -16.58 -0.57%
FTSE All-Share 2,809.41 -16.60 -0.59%
FTSEurofirst 300 992.81 -4.04 -0.41%
Pharmaceuticals & Biotechnology 9,464.29 -32.16 -0.34%
techMARK 1,943.98 -12.98 -0.66%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,421.50p
Change Today -2.00p
% Change -0.14 %
52 Week High 1,497.00p
52 Week Low 1,205.00p
Volume 7,337,610
Shares Issued 5,036m
Market Cap £71,582m
Beta 0.52
RiskGrade 74

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average
Price Trend
61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average
32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average
Income
71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average
55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average

What The Brokers Say

Strong Buy 12
Buy 3
Neutral 17
Sell 3
Strong Sell 0
Total 35
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Special
Ex-Div 09-May-12 15-Feb-12
Paid 05-Jul-12 12-Apr-12
Amount 17.00p 5.00p

Trades for 16-May-2012

Time Volume / Share Price
16:51 5,600 @ 1,421.15p
16:46 435 @ 1,424.00p
16:44 4,003 @ 1,421.25p
16:42 3,000 @ 1,422.06p
16:36 2,500 @ 1,421.50p

GlaxoSmithKline Key Personnel

CEO Andrew P Witty

Top of Page